Zachary Helft, PhD

Dr. Zachary Helft co-founded C. Light and brings over 10 years of neuroscience and regulatory experience to the team. He worked in the Technical Process Support team at Regeneron Pharmaceuticals to develop and transfer a GMP biologics manufacturing process to an international site. He was also part of regulatory interactions to manage quality systems documentation. Dr. Helft helped to launch Regeneron’s first large-scale biologic to the market, Eylea. He is the author of multiple research articles and two successful grant applications. Dr. Helft brings his GMP and regulatory background from his time at Regeneron and mixes it with his scientific background in neuroscience. He was educated at Colgate University (B.S. in Cellular Neuroscience) and UC Berkeley (Ph.D. in Vision Science).